299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details


臨床試験数 : 1,695 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05095246
(ClinicalTrials.gov)
March 8, 202227/8/2021A Study of Inhaled KB407 for the Treatment of Cystic FibrosisA Phase I Study of Inhaled KB407, a Replication-Incompetent, Non-Integrating Vector Expressing Human Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), for the Treatment of Cystic FibrosisCystic FibrosisBiological: KB407 (Nebulization)Krystal Biotech, Inc.Novotech (Australia) Pty LimitedRecruiting18 YearsN/AAll13Phase 1Australia